Linear Diagnostics: Funding, Investors & Team (Oct 2026)
Linear Diagnostics Limited (LDL) is a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. The technology provides significant advantages over the current state of the art allowing a more rapid detection of multiple targets using a single simple reagent
Linear Diagnostics has raised $2.5M across 3 funding rounds on record, the most recent an undisclosed round of $1.4M announced in Jun 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Linear Diagnostics Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Linear Diagnostics Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Linear Diagnostics raised $1.1M in an undisclosed round announced in Feb 2021.
2.3 years later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
2 years later, an undisclosed round of $1.4M was announced in Jun 2025.
Linear Diagnostics Founders and Leadership Team
Contact details for the Linear Diagnostics team: 1 of 2 have an email address on file.
Start 14-day free trial →Linear Diagnostics Funding Compared to Other Biotechnology Startups
Linear Diagnostics' latest round of $1.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Linear Diagnostics in Biotechnology and Birmingham
Companies Similar to Linear Diagnostics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Linear Diagnostics Funding FAQs
What does Linear Diagnostics do?
Linear Diagnostics Limited (LDL) is a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. The technology provides significant advantages over the current state of the art allowing a more rapid detection of multiple targets using a single simple reagent
How much funding has Linear Diagnostics raised?
Linear Diagnostics has raised $2.5M across 3 rounds on record. The most recent is an undisclosed round of $1.4M announced in Jun 2025.
When did Linear Diagnostics last raise funding?
Linear Diagnostics' most recent funding round on record is an undisclosed round of $1.4M, announced in Jun 2025.
Who founded Linear Diagnostics?
FundedIQ lists Matthew Hicks (Founder) at Linear Diagnostics.
Who is the CEO of Linear Diagnostics?
Brendan Farrell is listed as CEO at Linear Diagnostics.
Where is Linear Diagnostics headquartered?
Linear Diagnostics is based in Birmingham, United Kingdom.
How many employees does Linear Diagnostics have?
Linear Diagnostics is in the 1-10 employee band.
How does Linear Diagnostics' funding compare to other Biotechnology startups?
Linear Diagnostics' latest round of $1.4M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Linear Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Linear Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.